Advanced search
Publication Cover
Gut Microbes Volume 12, 2020 - Issue 1
Submit an article Journal homepage
6,373
Views
23
CrossRef citations to date
0
Altmetric
Review

Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection

Shakhinur Islam Mondala APC Microbiome Ireland, University College Cork, Cork, Ireland;b Genetic Engineering and Biotechnology Department, Shahjalal University of Science and Technology, Sylhet, BangladeshView further author information
,
Lorraine A. Drapera APC Microbiome Ireland, University College Cork, Cork, Ireland;c School of Microbiology, University College Cork, Cork, IrelandView further author information
,
R Paul Rossa APC Microbiome Ireland, University College Cork, Cork, Ireland;c School of Microbiology, University College Cork, Cork, Ireland;d Teagasc Food Research Centre, Moorepark, Cork, IrelandORCID Iconhttps://orcid.org/0000-0003-4876-8839View further author information
ORCID Icon &
Colin Hilla APC Microbiome Ireland, University College Cork, Cork, Ireland;c School of Microbiology, University College Cork, Cork, IrelandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8527-1445View further author information
ORCID Icon
Article: 1813533 | Received 06 May 2020, Accepted 11 Aug 2020, Published online: 28 Sep 2020

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jujun Zhou, John R. Horton, Dan Yu, Ren Ren, Robert M. Blumenthal, Xing Zhang & Xiaodong Cheng. (2022) Repurposing epigenetic inhibitors to target the Clostridioides difficile-specific DNA adenine methyltransferase and sporulation regulator CamA. Epigenetics 17:9, pages 970-981.
Read now

Articles from other publishers (22)

Sara Bano, Noor Hassan, Muhammad Rafiq, Farwa Hassan, Maliha Rehman, Naveed Iqbal, Hazrat Ali, Fariha Hasan & Ying-Qian Kang. (2023) Biofilms as Battlefield Armor for Bacteria against Antibiotics: Challenges and Combating Strategies. Microorganisms 11:10, pages 2595.
Crossref
Andrew A. Umansky & Louis Charles Fortier. (2023) The long and sinuous road to phage-based therapy of Clostridioides difficile infections. Frontiers in Medicine 10.
Crossref
Sebastian Braetz, Peter Schwerk, Nara Figueroa-Bossi, Karsten Tedin & Marcus Fulde. (2023) Prophage Gifsy-1 Induction in Salmonella enterica Serovar Typhimurium Reduces Persister Cell Formation after Ciprofloxacin Exposure. Microbiology Spectrum 11:4.
Crossref
Adam Jędrusiak, Wojciech Fortuna, Joanna Majewska, Andrzej Górski & Ewa Jończyk-Matysiak. (2023) Phage Interactions with the Nervous System in Health and Disease. Cells 12:13, pages 1720.
Crossref
Hamideh Raeisi, Maryam Noori, Masoumeh Azimirad, Seyed Reza Mohebbi, Hamid Asadzadeh Aghdaei, Abbas Yadegar & Mohammad Reza Zali. (2023) Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives. Gut Pathogens 15:1.
Crossref
Huihui Zhang, Xinyuan Zhang, Siyu Liang, Jing Wang, Yao Zhu, Wanjiang Zhang, Siguo Liu, Stefan Schwarz & Fang Xie. (2023) Bactericidal synergism between phage endolysin Ply2660 and cathelicidin LL-37 against vancomycin-resistant Enterococcus faecalis biofilms. npj Biofilms and Microbiomes 9:1.
Crossref
Jujun Zhou, John R. Horton, Martina Menna, Francesco Fiorentino, Ren Ren, Dan Yu, Taraneh Hajian, Masoud Vedadi, Giulia Mazzoccanti, Alessia Ciogli, Elmar Weinhold, Michael Hüben, Robert M. Blumenthal, Xing Zhang, Antonello Mai, Dante Rotili & Xiaodong Cheng. (2022) Systematic Design of Adenosine Analogs as Inhibitors of a Clostridioides difficile- Specific DNA Adenine Methyltransferase Required for Normal Sporulation and Persistence . Journal of Medicinal Chemistry 66:1, pages 934-950.
Crossref
Molly Mitchell, Scott V. Nguyen, Guerrino MacoriDeclan BoltonGeoff McMullanDenise DrudySéamus Fanning. (2022) Clostridioides difficile as a Potential Pathogen of Importance to One Health: A Review . Foodborne Pathogens and Disease 19:12, pages 806-816.
Crossref
Ngozi Joannes Anyaegbunam, Chijioke Chinedu Anekpo, Zikora Kizito Glory Anyaegbunam, Yandev Doowuese, Chinwe Blessing Chinaka, Oluchi Joannes Odo, Hyelnaya Cletus Sharndama, Onyekachi Philomena Okeke & Ifeanyi Elibe Mba. (2022) The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects. Microbiological Research 264, pages 127155.
Crossref
Carola Venturini, Aleksandra Petrovic Fabijan, Alicia Fajardo Lubian, Stefanie Barbirz & Jonathan Iredell. (2022) Biological foundations of successful bacteriophage therapy. EMBO Molecular Medicine 14:7.
Crossref
Vineeth M. Vijayan, Melissa Walker, J. Jeff Morris & Vinoy Thomas. (2022) Recent mitigation strategies in engineered healthcare materials towards antimicrobial applications. Current Opinion in Biomedical Engineering 22, pages 100377.
Crossref
Karla Cristina P. Cruz, Laura O. Enekegho & David T. Stuart. (2022) Bioengineered Probiotics: Synthetic Biology Can Provide Live Cell Therapeutics for the Treatment of Foodborne Diseases. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Wichuda Phothichaisri, Surang Chankhamhaengdecha, Tavan Janvilisri, Jirayu Nuadthaisong, Tanaporn Phetruen, Robert P. Fagan & Sittinan Chanarat. (2022) Potential Role of the Host-Derived Cell-Wall Binding Domain of Endolysin CD16/50L as a Molecular Anchor in Preservation of Uninfected Clostridioides difficile for New Rounds of Phage Infection. Microbiology Spectrum 10:2.
Crossref
Dhrati V. Patangia, Cornelius Anthony Ryan, Eugene Dempsey, Reynolds Paul Ross & Catherine Stanton. (2022) Impact of antibiotics on the human microbiome and consequences for host health. MicrobiologyOpen 11:1.
Crossref
Narjes Noori Goodarzi, Sepideh Fereshteh, Omid Azizi, Hamzeh Rahimi, Negin Bolourchi & Farzad Badmasti. (2022) Subtractive genomic approach toward introduction of novel immunogenic targets against Clostridioides difficile: Thinking out of the box. Microbial Pathogenesis 162, pages 105372.
Crossref
Marco Túlio Pardini Gontijo, Genesy Perez Jorge & Marcelo Brocchi. (2021) Current Status of Endolysin-Based Treatments against Gram-Negative Bacteria. Antibiotics 10:10, pages 1143.
Crossref
Hidehito Matsui, Jumpei Uchiyama, Masaya Ogata, Tadahiro Nasukawa, Iyo Takemura-Uchiyama, Shin-ichiro Kato, Hironobu Murakami, Masato Higashide & Hideaki Hanaki. (2021) Use of Recombinant Endolysin to Improve Accuracy of Group B Streptococcus Tests. Microbiology Spectrum 9:1.
Crossref
Agnieszka Morzywolek, Magdalena Plotka, Anna-Karina Kaczorowska, Monika Szadkowska, Lukasz P. Kozlowski, Dariusz Wyrzykowski, Joanna Makowska, Jerel J. Waters, Steven M. Swift, David M. Donovan & Tadeusz Kaczorowski. (2021) Novel Lytic Enzyme of Prophage Origin from Clostridium botulinum E3 Strain Alaska E43 with Bactericidal Activity against Clostridial Cells. International Journal of Molecular Sciences 22:17, pages 9536.
Crossref
Jacob M. Furlon, Spencer J. Mitchell, Chris Bailey‐Kellogg & Karl E. Griswold. (2021) Bioinformatics‐driven discovery of novel Clostridioides difficile lysins and experimental comparison with highly active benchmarks . Biotechnology and Bioengineering 118:7, pages 2482-2492.
Crossref
Jujun Zhou, John R. Horton, Robert M. Blumenthal, Xing Zhang & Xiaodong Cheng. (2021) Clostridioides difficile specific DNA adenine methyltransferase CamA squeezes and flips adenine out of DNA helix. Nature Communications 12:1.
Crossref
Shakhinur Islam Mondal, Arzuba Akter, Lorraine A. Draper, R. Paul Ross & Colin Hill. (2021) Characterization of an Endolysin Targeting Clostridioides difficile That Affects Spore Outgrowth. International Journal of Molecular Sciences 22:11, pages 5690.
Crossref
BG Andryukov. (2021) Nanotechnologies in the Light of Modern Antibacterial Strategies: A Review. ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT, pages 67-77.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.